Deepank Utkhede is Chief Process Biochemist at Vantage and has over 20 years of experience in pharmaceutical development and manufacturing. His background in the pharmaceutical industry has helped with designing robust and commercially scalable hemp extraction and finished product manufacturing processes at Vantage. Deepank has worked extensively in the development and production of pharmaceutical products including injectables, topicals, and oral products. Deepank has played a large role in the development of Vantage’s 62,000 sq ft. manufacturing facilities located in Greeley, Colorado and the attainment of the company’s ICH Q7 and WHO GMP certifications.
Vantage Hemp CO. has made this transition by joining the European Industrial Hemp Associations’s (EIHA) Novel Food Consortium.
Vantage is a global leader in the production of CBD extracts with its facilities achieving ICH Q7 and WHO Good Manufacturing Practices (GMP) certification.
The ICH Q7A Good Manufacturing Practice Guidance for Pharmaceutical APIs is intended for the manufacturing of Pharmaceutical APIs